• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[庞贝病成人型]

[Adult form of Pompe disease].

作者信息

Ziółkowska-Graca Bozena, Kania Aleksander, Zwolińska Grazyna, Nizankowska-Mogilnicka Ewa

机构信息

Klinika Pulmonologii, II Katedra Chorób Wewnetrznych Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie Kierownik Kliniki.

出版信息

Pneumonol Alergol Pol. 2008;76(5):396-9.

PMID:19003770
Abstract

Pompe disease (glycogen-storage disease type II) is an autosomal recessive disorder caused by a deficiency of lysosomal acid alpha-glucosidase (GAA), leading to the accumulation of glycogen in the lysosomes primarily in muscle cells. In the adult form of the disease, proximal muscle weakness is noted and muscle volume is decreased. The infantile form is usually fatal. In the adult form of the disease the prognosis is relatively good. Muscle weakness may, however, interfere with normal daily activities, and respiratory insufficiency may be associated with obstructive sleep apnea. Death usually results from respiratory failure. Effective specific treatment is not available. Enzyme replacement therapy with recombinant human GAA (rh-GAA) still remains a research area. We report the case of a 24-year-old student admitted to the Department of Pulmonary Diseases because of severe respiratory insufficiency. Clinical symptoms such as dyspnea, muscular weakness and increased daytime sleepiness had been progressing for 2 years. Clinical examination and increased blood levels of CK suggested muscle pathology. Histopathological analysis of muscle biopsy, performed under electron microscope, confirmed the presence of vacuoles containing glycogen. Specific enzymatic activity of alpha-glucosidase was analyzed confirming Pompe disease. The only effective method to treat respiratory insufficiency was bi-level positive pressure ventilation. Respiratory rehabilitation was instituted and is still continued by the patient at home. A high-protein, low-sugar diet was proposed for the patient. Because of poliglobulia low molecular weight heparin was prescribed. The patient is eligible for experimental replacement therapy with rh-GAA.

摘要

庞贝病(II型糖原贮积病)是一种常染色体隐性疾病,由溶酶体酸性α-葡萄糖苷酶(GAA)缺乏引起,导致糖原主要在肌肉细胞的溶酶体中蓄积。在成人型疾病中,可观察到近端肌无力且肌肉体积减小。婴儿型通常是致命的。在成人型疾病中,预后相对较好。然而,肌无力可能会干扰正常的日常活动,呼吸功能不全可能与阻塞性睡眠呼吸暂停有关。死亡通常由呼吸衰竭导致。目前尚无有效的特异性治疗方法。重组人GAA(rh-GAA)酶替代疗法仍处于研究阶段。我们报告了一名24岁学生的病例,该学生因严重呼吸功能不全入住肺病科。诸如呼吸困难、肌无力和日间嗜睡加重等临床症状已持续进展两年。临床检查及血液中肌酸激酶水平升高提示存在肌肉病变。在电子显微镜下进行的肌肉活检组织病理学分析证实存在含糖原的空泡。对α-葡萄糖苷酶的特异性酶活性进行分析,确诊为庞贝病。治疗呼吸功能不全的唯一有效方法是双水平正压通气。已开展呼吸康复治疗,患者在家中仍在继续进行。为患者建议了高蛋白、低糖饮食。由于红细胞增多症,开具了低分子量肝素。该患者符合rh-GAA实验性替代疗法的条件。

相似文献

1
[Adult form of Pompe disease].[庞贝病成人型]
Pneumonol Alergol Pol. 2008;76(5):396-9.
2
[A retrospective study of six patients with late-onset Pompe disease].六例晚发型庞贝病患者的回顾性研究
Rev Neurol (Paris). 2008 Apr;164(4):336-42. doi: 10.1016/j.neurol.2007.09.008.
3
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II.严重成人型II型糖原贮积病的酶替代疗法。
Adv Ther. 2008 Aug;25(8):820-9. doi: 10.1007/s12325-008-0086-y.
4
Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.重组酸性α-葡萄糖苷酶(rhGAA)在经典型婴儿庞贝病患者中的安全性和有效性:一项II期临床试验的结果
Neuromuscul Disord. 2005 Jan;15(1):24-31. doi: 10.1016/j.nmd.2004.10.009. Epub 2004 Nov 26.
5
Late form of Pompe disease with glycogen storage in peripheral nerves axons.庞贝病的晚期形式,其糖原储存在周围神经轴突中。
J Neurol Sci. 2011 Feb 15;301(1-2):59-62. doi: 10.1016/j.jns.2010.10.031. Epub 2010 Nov 25.
6
Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease.重组人酸性α-葡萄糖苷酶(rhGAA)治疗 Pompe 病所致严重呼吸衰竭的成年患者。
Neuromuscul Disord. 2011 Jul;21(7):477-82. doi: 10.1016/j.nmd.2011.04.001. Epub 2011 May 6.
7
Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.庞贝病:酶替代疗法时代当前诊断与治疗建议综述
J Clin Neuromuscul Dis. 2008 Jun;9(4):421-31. doi: 10.1097/CND.0b013e318176dbe4.
8
Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.酸性麦芽糖酶缺乏鹌鹑中酶疗法对庞贝病的临床和代谢纠正
J Clin Invest. 1998 Feb 15;101(4):827-33. doi: 10.1172/JCI1722.
9
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.替代庞贝病中的酸性α-葡萄糖苷酶:重组酶和转基因酶效力相当,但均不能完全清除II型肌纤维中的糖原。
Mol Ther. 2005 Jan;11(1):48-56. doi: 10.1016/j.ymthe.2004.09.017.
10
Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.使用源自牛奶的重组人α-葡萄糖苷酶对庞贝氏病进行长期静脉治疗。
Pediatrics. 2004 May;113(5):e448-57. doi: 10.1542/peds.113.5.e448.